HK1029929A1 - Opthalmic composition. - Google Patents

Opthalmic composition.

Info

Publication number
HK1029929A1
HK1029929A1 HK01100778A HK01100778A HK1029929A1 HK 1029929 A1 HK1029929 A1 HK 1029929A1 HK 01100778 A HK01100778 A HK 01100778A HK 01100778 A HK01100778 A HK 01100778A HK 1029929 A1 HK1029929 A1 HK 1029929A1
Authority
HK
Hong Kong
Prior art keywords
composition
sodium hyaluronate
range
conducting
opthalmic composition
Prior art date
Application number
HK01100778A
Other languages
English (en)
Inventor
Susanna Fergeus
Kerstin Lundberg
Ove Wik
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of HK1029929A1 publication Critical patent/HK1029929A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
  • Dental Preparations (AREA)
  • Luminescent Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK01100778A 1997-03-07 2001-02-02 Opthalmic composition. HK1029929A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700827A SE9700827D0 (sv) 1997-03-07 1997-03-07 Ophthalmic composition
PCT/SE1998/000401 WO1998039015A1 (en) 1997-03-07 1998-03-06 Opthalmic composition

Publications (1)

Publication Number Publication Date
HK1029929A1 true HK1029929A1 (en) 2001-04-20

Family

ID=20406068

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100778A HK1029929A1 (en) 1997-03-07 2001-02-02 Opthalmic composition.

Country Status (14)

Country Link
US (1) US6086597A (de)
EP (1) EP1023077B1 (de)
JP (2) JP3481952B2 (de)
AT (1) ATE288274T1 (de)
AU (1) AU749522B2 (de)
CA (1) CA2282757C (de)
DE (1) DE69828894T2 (de)
DK (1) DK1023077T3 (de)
ES (1) ES2236890T3 (de)
HK (1) HK1029929A1 (de)
IL (1) IL131663A0 (de)
PT (1) PT1023077E (de)
SE (1) SE9700827D0 (de)
WO (1) WO1998039015A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018382A1 (en) * 2001-07-17 2003-01-23 Pflugfelder Stephen C. Process for improving vision
US20050064012A1 (en) * 2001-07-17 2005-03-24 Baylor College Of Medicine Process for causing myopic shift in vision
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
US8802651B2 (en) * 2004-06-30 2014-08-12 Abbott Medical Optics Inc. Hyaluronic acid in the enhancement of lens regeneration
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
WO2007030623A2 (en) * 2005-09-07 2007-03-15 Amo Regional Holdings Bi-modal hyaluronate solution
JP2007145765A (ja) * 2005-11-29 2007-06-14 Menicon Co Ltd 眼科手術用組成物
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US20130108550A1 (en) 2011-10-26 2013-05-02 Abbott Cardiovasculr Systems, Inc. Bioabsorbable Co-Filler for Cerebrovascular Aneurysms
JP6357228B2 (ja) 2013-07-10 2018-07-11 マトリックス バイオロジー インスティテュート 高い弾性を有するヒアルロナンの組成物およびその使用
WO2017053339A1 (en) 2015-09-24 2017-03-30 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
JPWO2021220712A1 (de) * 2020-04-30 2021-11-04

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112350A (en) * 1986-10-16 1992-05-12 Cbs Lens, A California General Partnership Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth and regeneration of the stroma
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
US4978352A (en) * 1989-06-07 1990-12-18 Fedorov Svjatoslav N Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant
EP0414373B2 (de) * 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu
US5492936A (en) * 1990-11-30 1996-02-20 Allergan, Inc. Bimodal molecular weight hyaluronate formulations and methods for using same
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
WO1995013766A1 (en) * 1993-11-18 1995-05-26 Allergan, Inc. Deformable lens insertion apparatus
US5604244A (en) * 1995-06-07 1997-02-18 Alcon Laboratories, Inc. Intraocular irrigating solution containing a polyamine antagonist

Also Published As

Publication number Publication date
IL131663A0 (en) 2001-01-28
EP1023077A1 (de) 2000-08-02
JP2004131489A (ja) 2004-04-30
CA2282757A1 (en) 1998-09-11
PT1023077E (pt) 2005-04-29
ES2236890T3 (es) 2005-07-16
ATE288274T1 (de) 2005-02-15
SE9700827D0 (sv) 1997-03-07
AU6644898A (en) 1998-09-22
WO1998039015A1 (en) 1998-09-11
AU749522B2 (en) 2002-06-27
DK1023077T3 (da) 2005-05-30
EP1023077B1 (de) 2005-02-02
DE69828894T2 (de) 2006-01-19
DE69828894D1 (de) 2005-03-10
JP3481952B2 (ja) 2003-12-22
JP2001515531A (ja) 2001-09-18
US6086597A (en) 2000-07-11
CA2282757C (en) 2003-06-03

Similar Documents

Publication Publication Date Title
HK1029929A1 (en) Opthalmic composition.
DK199801679A (da) Præparat samt kit til brug ved intraoculære operationer
KR850700007A (ko) 내안렌즈 이식체
EA199700286A1 (ru) Соединение для офтальмологической хирургии и способ ее осуществления
AU4685800A (en) Multifocal phakic intraocular lens
CA2193543A1 (en) Sodium hyaluronate based ophthalmic formulation for use in eye surgery
WO2002049611A3 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
MXPA03005922A (es) Metodo para tratar glaucoma ib.
UA61133C2 (uk) Офтальмологічний розчин, корисний як штучні сльози, що містить глікоген
AU755837B2 (en) Ocular tissue regeneration inducer
WO2000064425A3 (en) Miotic agents and hypertonic agents containing ophthalmic compositions
GB2394899A (en) Ophthalmic tissue barrier
AU3430399A (en) Ocular irrigating solution
ATE293969T1 (de) Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie
MX9603974A (es) Aparato para sellar un recipiente.
RU94022796A (ru) Способ имплантации искусственного хрусталика в афакичный глаз при наличии грыжи стекловидного тела
UA39527A (uk) Спосіб лікування опіку очей

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100306